Clik here to view.
New Study Validates Sports Data Labs’ Real-Time Remote Health Monitoring...
DETROIT Sports Data Labs, Inc. (SD Labs), an award-winning leader in collection, analysis and distribution of real-time Human Data from on-body sensors and sensing systems in professional sports and...
View ArticleClik here to view.
PerkinElmer’s Horizon Discovery CHOSOURCE Cell Line Supports Trinomab...
WALTHAM, Mass. PerkinElmer, a global leader committed to innovating for a healthier world, today announced that its Horizon Discovery CHOSOURCE™ CHO-K1GS knockout cell line licensed by Trinomab...
View ArticleClik here to view.
L＆T Technology Services荣获美国2021年度BIG创新大奖
印度班加罗尔 (美国商业资讯)–全球领先的工程服务单一业务公司L&T Technology Services Limited (BSE: 540115, NSE: LTTS)宣布，其两款数字化解决方案获得了2021年度“产品”类别BIG创新大奖(BIG Innovation Awards)，该奖由美国商业情报集团(Business Intelligence Group)颁发。...
View ArticleClik here to view.
珀金埃尔默的Horizon Discovery CHOSOURCE细胞系支持泰诺麦博开发世界首款进入临床试验的破伤风毒素mAb药物
马萨诸塞州沃尔瑟姆 (美国商业资讯)–积极开展创新以打造更健康世界的全球领导者珀金埃尔默(PerkinElmer)今天宣布，其向中国广州泰诺麦博生物技术有限公司(Trinomab Biotech. Co., Ltd., www.trinomab.com)授权的Horizon Discovery CHOSOURCE™...
View ArticleClik here to view.
Navient耳鼻喉(ENT)手术产品获中国监管部门许可
多伦多 (美国商业资讯)–外科手术导航系统领导者ClaroNav Kolahi Inc欣然宣布，公司已获得中国国家药品监督管理局(NMPA)的监管许可，今后可在中国市场推广和销售其Navient ENT产品。此前，Navient ENT已分别获得美国食品药品监督管理局、欧盟CE认证、加拿大卫生部、韩国食品医药品安全部、巴西国家卫生监督局和中国台湾地区卫生福利部食品药物管理署等监管机构的许可。...
View ArticleClik here to view.
Pregna International Ltd teams up with the Vayu Global Health Foundation to...
MUMBAI, India Pregna International Ltd – a leading women’s healthcare company – has partnered with Dr. Thomas Burke’s Vayu Global Health Initiative to introduce an economical solution to Post-Partum...
View ArticleClik here to view.
Huami Corp Invests $5 Million in Hyperfine Research D Round to Support...
BEIJING & CUPERTINO, Calif. Huami Corp. (NYSE: HMI) today announced that it has invested $5 million in Hyperfine Research’s D round of funding, which closed on February 3, 2021. Huami’s mission...
View ArticleClik here to view.
Evaluate Vantage 2020 Review: Biopharma IPOs and Venture Financing Break...
LONDON & BOSTON & TOKYO The top 600 biopharma firms added $487 billion in market capitalisation in 2020, according to the Evaluate Vantage Pharma, Biotech & Medtech 2020 in Review...
View ArticleClik here to view.
HD Medical’s HD Steth Screens Over 50,000 Children for Congenital Heart Defects
SANTA CLARA, Calif. In recognition of World Congenital Heart Defects (CHD) Awareness week, HD Medical Inc. today announces it has screened over 50,000 children for CHDs using HD Steth™. These...
View ArticleClik here to view.
スミス・ディテクションのBioFlashが空中のCOVID-19を検出可能であることを実証
ロンドン （ビジネスワイヤ） — 脅威検出・セキュリティースクリーニング技術の世界的リーダー企業であるスミス・ディテクションは本日、米国陸軍感染症医学研究所（USAMRIID）が実施した試験を受けて、BioFlash® Biological Identifier（バイオフラッシュ・バイオロジカル・アイデンティファイアー）が空中のSARS-CoV-2を検出可能であることを報告します。...
View ArticleClik here to view.
Shape Memory Medical Receives PMDA Approval for the IMPEDE-FX Embolization Plug
SANTA CLARA, Calif. Shape Memory Medical Inc. announced today that it has received approval from Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) to market its IMPEDE®-FX Embolization Plug...
View ArticleClik here to view.
スリランカでの研究により、Masimo SET®パルスオキシメトリーを使用した重症先天性心疾患（CCHD）スクリーニングの利点を実証する証拠が拡大
スイス・ヌーシャテル （ビジネスワイヤ） — マシモ（NASDAQ: MASI）は本日、Sri Lanka Journal of Child Health誌に掲載された前向き研究の結果を発表しました。本研究では、スリランカのコロンボの研究者らが、新生児を対象に、Masimo...
View ArticleClik here to view.
在斯里兰卡开展的研究扩充证据，证明使用Masimo SET®脉搏氧饱和度仪筛查危重型先天性心脏病(CCHD)所带来的益处
瑞士纳沙泰尔 (美国商业资讯)–Masimo (NASDAQ: MASI)今天发布在《斯里兰卡儿童健康杂志》(Sri Lanka Journal of Child Health)上发表的一项前瞻性研究结果，斯里兰卡科伦坡的研究人员使用Masimo...
View ArticleClik here to view.
Genetron Health Releases New Data Results of HCCscreen™ for Liver Cancer...
BEIJING Genetron Holdings Limited (“Genetron Health” or the “Company”, NASDAQ:GTH), a leading precision oncology platform company in China that specializes in molecular profiling tests, early cancer...
View ArticleClik here to view.
リムフローが包括的高度慢性下肢虚血患者の下肢切断を回避するための低侵襲技術の臨床試験で日本のPMDAから承認を取得
パリ （ビジネスワイヤ） — 重症の末梢動脈疾患（PAD）である包括的高度慢性下肢虚血（CLTI）を治療するための低侵襲技術の開発に取り組むパイオニア企業のリムフローは、LimFlow経皮的深部静脈動脈形成術（pDVA）システムを検討するために実施中のPROMISE...
View ArticleClik here to view.
Clik here to view.
TIGER试验显示，世界首款可调节血栓切除器械具有高安全性和有效性
以色列约克南和迈阿密 (美国商业资讯)–一项多中心试验显示，首款可调节、完全可视的支架取栓器优于传统支架取出器。这一最新突破性结果最近呈报于国际卒中大会，并发表于《卒中》(Stroke)杂志在线版。TIGER试验显示，TIGERTRIEVER™器械能恢复缺血性卒中期间的脑血流，评分比现有的自扩张式支架取栓器高11分，差异有统计学意义，而安全性相等。...
View ArticleClik here to view.
Rapid Medical Receives FDA Clearance for the First Adjustable Stent Retriever...
YOKNEAM, Israel & MIAMI Rapid Medical, developer of responsive, adjustable neurovascular devices, announces the FDA clearance of its TIGERTRIEVER™ revascularization device for use in the...
View ArticleClik here to view.
Clik here to view.
Toyoda Gosei Invests in Genial Light, a Medical Device Development Startup
KIYOSU, Japan Toyoda Gosei Co., Ltd. (TOKYO:7282) has invested in Genial Light Co., Ltd., a startup that develops testing equipment and other devices for medical institutions, with the aim of...
View Article